Cite

HARVARD Citation

    Haslett, K. et al. (n.d.). PO-0752: Isotoxic Intensity Modulated Radiotherapy in stage III NSCLC – A feasibility study. Radiotherapy and oncology. pp. S387-. [Online]. 
  
Back to record